Literature DB >> 9352988

Effects of chronic vasodilator therapy to enhance susceptibility to vasovagal syncope during upright tilt testing.

G Gaggioli1, N Bottoni, R Mureddu, G Foglia-Manzillo, G Mascioli, P Bartoli, G Musso, C Menozzi, M Brignole.   

Abstract

To evaluate the effect of chronic vasodilator therapy on susceptibility to vasovagal syncope, 45 patients with syncope and a positive response to tilt testing were randomly assigned to continue or to discontinue vasodilators. The study result demonstrated that chronic vasodilator therapy enhances susceptibility to vasovagal reaction during upright tilt testing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352988     DOI: 10.1016/s0002-9149(97)00613-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  [Commentary on the guidelines the diagnosis and the therapy of syncope--the European Society of Cardiology 2001 and the update 2004].

Authors:  K Seidl; A Schuchert; J Tebbenjohanns; W Hartung
Journal:  Z Kardiol       Date:  2005-09

2.  Management and therapy of vasovagal syncope: A review.

Authors:  Muhammet Ali Aydin; Tushar V Salukhe; Iris Wilke; Stephan Willems
Journal:  World J Cardiol       Date:  2010-10-26

3.  Early and late-onset syncope: insight into mechanisms.

Authors:  Parisa Torabi; Giulia Rivasi; Viktor Hamrefors; Andrea Ungar; Richard Sutton; Michele Brignole; Artur Fedorowski
Journal:  Eur Heart J       Date:  2022-06-06       Impact factor: 35.855

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.